Clik here to view.
Atox Bio Raising Millions Following Successful Clinical Trial
Israeli company Atox Bio Ltd. has reported a successful clinical trial of its AB103 treatment for Necrotizing Soft-Tissue Infection (NSTI). Financial magazine Globes reports that due to the successful...
View ArticleClik here to view.
BioControl Reports Positive Results On Early Stage Epilepsy Treatment Trial
Israeli company BioControl Medical, which develops implant for treating complex medical conditions, has reported positive results on its FitNeS treatment trial. The device was implanted in five...
View ArticleClik here to view.
PolyPid Announces Positive Results On Trial With Open Bone Fractures Treatment
PolyPid Ltd., an Israeli biotechnology company, announced today positive preliminary results of a first-in-man clinical trial with BonyPid. In the study, BonyPid demonstrated a clear, positive signal...
View ArticleClik here to view.
Hadassah Medical Center Researchers Find Cure For PNH
A team of Israeli researchers from Hadassah Medical Center has achieved a significant breakthrough in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare, potentially life-threatening...
View ArticleClik here to view.
Brainsway’s Deep TMS System Wins FDA Approval
Israeli company Brainsway Ltd., which develops innovative devices for treatment of mental disorders using magnetic pulses, has announced that it has received US Food and Drug Administration (FDA)...
View ArticleClik here to view.
Brainsway Receives Health Canada Approval For Depression Treatment
Israeli company Brainsway Ltd. has received approval from the Health Canada for its Deep TMS treatment. The treatment, approved earlier this month by the American FDA, uses transcranial magnetic...
View ArticleClik here to view.
Brainsway Trial Shows Significant Results For Smoking Addiction Treatment
Israeli company Brainsway, which developed a device called Deep TMS (transcranial magnetic stimulation), for treating various brain-related disorders, has announced a successful trial of its treatment...
View ArticleClik here to view.
Pharmaceutical Company BiolineRX To Raise $15M
Israeli company BiolineRX, which is currently testing an innovative drug for treating schizophrenia, is planning a financing round, with a $15 million goal. “Calcalist” reports that the round is set to...
View ArticleClik here to view.
Brainsway Will Launch Deep TMS In The US
Israeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), will launch its Deep TMS product in the US this month. The device, which is...
View ArticleClik here to view.
Brainsway’s Deep TMS Treatment Approved By EU
Israeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has received the EU’s CE Marketing stamp of approval for its Deep TMS system. The...
View ArticleClik here to view.
Opthocare Raises $1.75M To Develop Amblyz Lazy Eye Treatment Glasses
Israeli startup Opthocare, which developed Lazy-Eye treatment glasses Amblys, has raised $1.75 million. Calcalist reports that the investment was made by prominent Israeli serial inventor and medical...
View ArticleClik here to view.
BioLineRX Wins FDA Orphan Drug Status For Rare Leukemia Treatment
Israeli phramaceutcial company BioLineRX has won FDA approval for its BL-8040 acute myeloid leukemia treatment. The drug was given orphan drug status, which is given to treatments for conditions...
View ArticleClik here to view.
KAHR Medical Raises $2.35M
Israeli company KAHR Medical, which develops treatments for cancer and inflammatory disease, specifically lymphoma, has announced that it has raised $2.35 million from its shareholders at a company...
View ArticleClik here to view.
Teva Launches Generic High Blood Pressure Treatments
Teva Pharmaceutical Industries announced that it has launched sales of irbesartan and irbesartan-hydrochlorothiazide tablets, two generic versions of Sanofi Aventis’ high blood pressure treatments....
View ArticleClik here to view.
Biomed Company ConTIPI Acquired For $90M
Israeli Biomed company ConTIPI has been sold for approximately $90 million to an international company whose name has not been disclosed. ConTIPI, founded in 2002 by gynecologists Dr. Ilan Ziv and Zeev...
View ArticleClik here to view.
‘IMMUNE Pharmaceuticals’ Partners With Weizmann Institute
IMMUNE Pharmaceuticals, a developer of monoclonal antibodies, and Yeda, the technology transfer company of the Weizmann Institute of Science, announced a broad collaboration to develop antibody...
View ArticleClik here to view.
‘Compugen’: Positive Results For Cancer Treatment Protein
Compugen announced positive results for its trial of CGEN-15022, a membrane protein that was discovered by the company, as a treatment of multiple cancers such as liver, colorectal, lung and ovarian...
View ArticleClik here to view.
Pluristem Gains Approval For Muscle Regeneration Trial
Pluristem Therapeutics, a developer of placenta-based cell therapies, announced it has received approval from the Paul-Ehrlich-Institute (PEI), the medical regulatory body in Germany, to commence a...
View ArticleClik here to view.
Atox Bio’s Tissue Infection Treatment Fast-Tracked By FDA
The FDA has granted Israeli company Atox Bio’s tissue infection treatment AB103 fast track status. AB103 is designed to treat Necrotizing Soft Tissue Infections. The company will begin testing on 40...
View ArticleClik here to view.
Intec Pharma Gets US Patent For Parkinson’s Treatment
Israeli company Intec Pharma has announced that following the successful phase II clinical trial for its accordion capsule, the capsule and procedure will receive a US patent. The accordion capsule is...
View Article
